CDC Says Gonorrhea On List Of 'Superbugs'

[matcom]

<snip>

ATLANTA (AP) U.S. health officials are recommending wider use of a new drug to treat gonorrhea because the sexually transmitted disease is steadily becoming resistant to the longtime standard antibiotic.

Fluoroquinolones, a class of antibiotics that includes Cipro, have been the most common way to treat the bacterial disease since the early 1990s. Since then, gonorrhea has grown increasingly resistant to those drugs.

On Thursday, the Centers for Disease Control and Prevention recommended that a different class of antibiotics, cephalosporins, be used instead.

``Gonorrhea has now joined the list of other superbugs for which treatment options have become dangerously few,'' said Dr. Henry Masur, president of the Infectious Disease Society of America. ``To make a bad problem even worse, we're also seeing a decline in the development of new antibiotics to treat these infections.''

The CDC made the new recommendation after discovering that nearly 7 percent of gonorrhea cases among heterosexual men in a survey of 26 U.S. cities last year had drug-resistant strains of the disease. In 2001, only about 0.6 percent of gonorrhea cases among heterosexual men were drug-resistant.

``That leaves us with a single class of highly effective an disease. In men, it can cause epididymitis, a painful condition of the testicles that can lead to infertility if untreated, the CDC said.

In the survey of 26 cities last year, Philadelphia had the highest percentage of drug-resistant cases with almost 27 percent, followed by areas in California and Hawaii where health officials long have known about gonorrhea drug resistance.

A quarter of gonorrhea cases among heterosexual men in Honolulu, San Diego and Orange County, Calif. were drug-resistant, followed by 22.5 percent of cases in San Francisco and 22 percent in Long Beach, Calif. More than 15 percent of cases in Miami were drug-resistant to the bacteria, the CDC said.

http://cbs13.com/nationalwire/ResistantGonorrhea_a_a_-----/resources_news_html